This inventor holds 1 USPTO granted patent. Top assignee: The University of Texas System. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2005
Title: Meghan Kunkel: Innovator in Viral Capsid Technology
Introduction
Meghan Kunkel is a prominent inventor based in Galveston, TX (US). She has made significant contributions to the field of virology, particularly in the development of viral pseudo-capsids. Her work focuses on creating innovative solutions for hepatitis C virus (HCV) infections.
Latest Patents
Meghan Kunkel holds a patent for "Viral pseudo-capsids including assembly agonists and antagonists." This patent involves recombinant hepatitis C virus (HCV) capsid proteins that self-assemble into large spherical virus-like particle structures. These viral capsids include conformational antigenic epitopes, which can be utilized as vaccines to induce a cellular or humoral immune response. Additionally, the self-assembling capsid proteins may serve as elements in diagnostic immunoassay procedures for HCV infection. She has 1 patent to her name.
Career Highlights
Kunkel is affiliated with the University of Texas System, where she continues her research and development in virology. Her innovative work has the potential to impact vaccine development and diagnostic methods for viral infections.
Collaborations
Some of her notable coworkers include Marta Lorinczi and Stanley J Watowich, who contribute to her research endeavors.
Conclusion
Meghan Kunkel's contributions to viral capsid technology highlight her role as an innovator in the field of virology. Her work not only advances scientific understanding but also holds promise for future medical applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile